Matthew D. Dallas serves as Executive at AVEO PHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, Matthew D. Dallas has executed 8 insider transactions totaling $108.1K, demonstrating a bearish approach to their equity position. Their most recent transaction on Mar 1, 2017 involved transacting 2,708 shares valued at $125.9K.
Matthew D. Dallas currently holds 40,128 shares of AVEO PHARMACEUTICALS INC (AVEO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Matthew D. Dallas has been a net seller of AVEO stock. They have purchased $0 and sold $108.1K worth of shares.
Matthew D. Dallas's most recent insider trade was on Mar 1, 2017, when they sold 2,708 shares at $46.50 per share.
Get notified when new Form 4 filings are submitted
| $46.50 |
| Discretionary |
| Jan 3, 2017 | CLCD | $53.4K | Sale | 1,473 | $36.25 | Discretionary |
| Dec 1, 2016 | CLCD | $51.8K | Sale | 1,473 | $35.17 | Discretionary |
| Mar 4, 2016 | CLCD | $0 | Award | 37,500 | $N/A | Discretionary |
| Jan 16, 2015 | AVEO | $2.5K | Sale | 3,075 | $0.82 | Discretionary |
| Jan 7, 2015 | AVEO | $415 | Sale | 519 | $0.80 | Discretionary |
| Jan 6, 2015 | AVEO | $0 | Disposition | 1,485 | $N/A | Discretionary |